Literature DB >> 18487536

Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps.

Kyrre E Emblem1, Baard Nedregaard, Terje Nome, Paulina Due-Tonnessen, John K Hald, David Scheie, Olivera Casar Borota, Milada Cvancarova, Atle Bjornerud.   

Abstract

PURPOSE: To retrospectively compare the diagnostic accuracy of an alternative method used to grade gliomas that is based on histogram analysis of normalized cerebral blood volume (CBV) values from the entire tumor volume (obtained with the histogram method) with that of the hot-spot method, with histologic analysis as the reference standard.
MATERIALS AND METHODS: The medical ethics committee approved this study, and all patients provided informed consent. Fifty-three patients (24 female, 29 male; mean age, 48 years; age range, 14-76 years) with histologically confirmed gliomas were examined with dynamic contrast material-enhanced 1.5-T magnetic resonance (MR) imaging. CBV maps were created and normalized to unaffected white matter (normalized CBV maps). Four neuroradiologists independently measured the distribution of whole-tumor normalized CBVs and analyzed this distribution by classifying the values into area-normalized bins. Glioma grading was performed by assessing the normalized peak height of the histogram distributions. Logistic regression analysis and interobserver agreement were used to compare the proposed method with a hot-spot method in which only the maximum normalized CBV was used.
RESULTS: For the histogram method, diagnostic accuracy was independent of the observer. Interobserver agreement was almost perfect for the histogram method (kappa = 0.923) and moderate for the hot-spot method (kappa = 0.559). For all observers, sensitivity was higher with the histogram method (90%) than with the hot-spot method (55%-76%).
CONCLUSION: Glioma grading based on histogram analysis of normalized CBV heterogeneity is an alternative to the established hot-spot method, as it offers increased diagnostic accuracy and interobserver agreement. (c) RSNA, 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487536     DOI: 10.1148/radiol.2473070571

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  64 in total

1.  ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.

Authors:  Kenji Hirata; Shunsuke Terasaka; Tohru Shiga; Naoya Hattori; Keiichi Magota; Hiroyuki Kobayashi; Shigeru Yamaguchi; Kiyohiro Houkin; Shinya Tanaka; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-04       Impact factor: 9.236

2.  Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging.

Authors:  Won-Jin Moon; Jin Woo Choi; Hong Gee Roh; So Dug Lim; Young-Cho Koh
Journal:  Neuroradiology       Date:  2011-08-11       Impact factor: 2.804

3.  Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.

Authors:  Atsuko Arisawa; Yoshiyuki Watanabe; Hisashi Tanaka; Hiroto Takahashi; Chisato Matsuo; Takuya Fujiwara; Masahiro Fujiwara; Yasunori Fujimoto; Noriyuki Tomiyama
Journal:  Neuroradiology       Date:  2018-04-29       Impact factor: 2.804

4.  Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.

Authors:  Anna Latysheva; Kyrre Eeg Emblem; Petter Brandal; Einar Osland Vik-Mo; Jens Pahnke; Kjetil Røysland; John K Hald; Andrés Server
Journal:  Neuroradiology       Date:  2019-02-02       Impact factor: 2.804

5.  Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.

Authors:  Gian Marco Conte; Antonella Castellano; Luisa Altabella; Antonella Iadanza; Marcello Cadioli; Andrea Falini; Nicoletta Anzalone
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

6.  Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly.

Authors:  Ansgar Heck; Kyrre E Emblem; Olivera Casar-Borota; Jens Bollerslev; Geir Ringstad
Journal:  Endocrine       Date:  2015-10-16       Impact factor: 3.633

7.  Microvascular MRI and unsupervised clustering yields histology-resembling images in two rat models of glioma.

Authors:  Nicolas Coquery; Olivier Francois; Benjamin Lemasson; Clément Debacker; Régine Farion; Chantal Rémy; Emmanuel Luc Barbier
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-21       Impact factor: 6.200

8.  High- and low-grade glioma differentiation: the role of percentage signal recovery evaluation in MR dynamic susceptibility contrast imaging.

Authors:  Italo Aprile; Giorgia Giovannelli; Paola Fiaschini; Marco Muti; Anna Kouleridou; Nevia Caputo
Journal:  Radiol Med       Date:  2015-03-12       Impact factor: 3.469

9.  Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.

Authors:  Kiyohisa Kamimura; Masanori Nakajo; Tomohide Yoneyama; Yoshihiko Fukukura; Hirofumi Hirano; Yuko Goto; Masashi Sasaki; Yuta Akamine; Jochen Keupp; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

10.  Intravascular contrast agent T2* relaxivity in brain tissue.

Authors:  Vishal Patil; Jens H Jensen; Glyn Johnson
Journal:  NMR Biomed       Date:  2012-12-06       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.